Show Summary Details
Page of

Withdrawal of Respiratory Technology 

Withdrawal of Respiratory Technology
Chapter:
Withdrawal of Respiratory Technology
Author(s):

Beth Wagner

DOI:
10.1093/med/9780190204747.003.0049
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 18 August 2019

Respiratory failure can be defined as the inability of the lungs to provide adequate oxygenation or ventilation to sustain life. The symptoms of respiratory failure are distressing for patients and can lead to abrupt clinical deterioration. Advances in technology over the past decade have produced many life-sustaining therapies for patients with respiratory failure. Examples include high-flow oxygen therapy, invasive and noninvasive mechanically assisted breathing ventilation, prostacyclin therapy, and extracorporeal membrane oxygenation (ECMO). The APRN must understand the care of these complex patients when such therapies are discontinued.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.